BeOne Medicines AG (6160.HK) HKSE
Currency In HKD
AD
- General
- Statistics
- Historical Data
- Profile
- Financials
Valuation
| Market Cap | 32.66B |
| Enterprise Value | 29.16B |
| P/E Ratio | 63.93 |
| PEG Ratio | 0.03 |
| Price/Sales Ratio | 6.32 |
| Price/Book Ratio | 8.15 |
| Enterprise/Revenue | 5.68 |
| Enterprise/EBITDA | 31.48 |
Fiscal Year
| Fiscal Year | December 31, 2025 |
| Most Recent Quarter | June 30, 2026 |
Profitability
| Profit Margin | 0.11 |
| Operating Margin | 0.15 |
AD
Management Effectiveness
| Return On Assets | 0.07 |
| Return On Equity | 0.14 |
Income Statement
| Revenue | 5.35B |
| Revenue/Share | 4.22 |
| Gross Profit | 4.56B |
| EBITDA | 589.69M |
| Net Income | 287.36M |
| Diluted EPS | 0.2 |
Balance Sheet
| Total Cash | 5.1B |
| Total Cash/Share | 3.51 |
| Total Debt | 1.14B |
| Total Debt/Equity | 0.22 |
| Current Ratio | 3.4 |
| Book Value Per Share | 3.57 |
Price History
| 52-Week Change | 21.66 |
| 52-Week High | 235.6 |
| 52-Week Low | 153 |
| Moving Average 50 Days | 189.64 |
| Moving Average 200 Days | 190.3 |
Statistics
| Average Volume | 5.49M |
| Shares Outstanding | 1.33B |
| % Held by Institutions | 0.01 |
Dividend And Splits
| Trailing Annual Dividend Rate | 0 |
| Trailing Annual Dividend Yield | 0 |
| Payout Ratio | 0 |
| Last Split Factor | N/A |
| Last Split Date | N/A |
AD
